I.M. Sechenov First Moscow State Medical University
University / College
Location:
Moscow,
Russian Federation (RU)
ISNI: 0000000122888774
ROR: https://ror.org/02yqqv993
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study (2019)
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, et al.
Journal article
Ansa cervicalis - A new classification approach (2019)
Shvedavchenko AI, Oganesyan MV, Hammer C, Paulsen F, Bakhmet AA
Journal article
European expert consensus statement on therapeutic goals in Fabry disease (2018)
Wanner C, Arad M, Baron R, Burlina A, Elliott PM, Feldt-Rasmussen U, Fomin VV, et al.
Journal article
Coding and Non-coding: Molecular Portrait of GIST and its Clinical Implication (2018)
Bure I, Haller F, Zaletaev DV
Journal article
RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK (2018)
Elhai M, Distler O, Smith V, Matucci-Cerinic M, Alegre-Sancho JJ, Truchetet ME, Braun-Moscovici Y, et al.
Conference contribution
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial (2016)
Petrie JR, Marso SP, Bain SC, Franek E, Jacob S, Masmiquel L, Leiter LA, et al.
Journal article